New approach boosts HIV prevention in men who use stimulants
NCT ID NCT04899024
First seen Feb 06, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This study tested a program to help gay and bisexual men who use stimulants (like cocaine or meth) stick to their daily HIV prevention pill (PrEP). The program combined a smartphone-based reward system for taking PrEP with a short counseling course on managing emotions. The goal was to see if this approach could lower the risk of getting HIV by improving pill-taking habits and reducing risky sex.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
University of Miami Miller School of Medicine
Miami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.